If There Are No Side Effects, This Must Be Honduras

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Culled from The Physician’s Desk Reference — the standard sourcebook for U.S. doctors, containing information drug companies supply about their products — and comparable foreign guidebooks.

Chart excerpted by Carolyn Marshall

Tetracycline

[ANTIBIOTIC USED AGAINST VARIOUS INFECTIONS; LEDERLE LABORATORIES.]

Ovulen

[BIRTH CONTROL PILLS; G.D. SEARLE CO.]

Imipramine

[ANTI-DEPRESSANT; CIBA-GEIGY.]

UNITED STATES Caution against use:

By infants, children; during pregnancy; with liver or kidney impairment (latter can be fatal) or if overly sensitive to light.

Adverse reactions publicized:

Vomiting, diarrhea, nausea, upset stomach, rashes, kidney poisoning. Can poison fetus.

Caution against use:

If patient has tendency to blood clot, liver dysfunction, abnormal vaginal bleeding, epilepsy, migraine, asthma, heart trouble.

Adverse reactions publicized:

Nausea, loss of hair, nervousness, jaundice, high blood pressure, weight change, headaches.

Caution against use:

If patient has heart disease, history of urinary retention, history of seizures, manic disorder or is on typhoid medication. Not recommended for children or during pregnancy.

Adverse reactions publicized:

Hypertension, stroke, stumbling, delusions, insomnia, numbness, dry mouth, blurred vision, constipation, itching, nausea, vomiting, loss of appetite, diarrhea, sweating.

Tetracycline Ovulen Imipramine
MEXICO Caution against use:

By infants, children; during pregnancy or if overly sensitive to light.

Adverse reactions publicized

Vomiting, diarrhea, nausea, upset stomach.

Caution against use:

If patient has tendency to blood clot, liver dysfunction.

Adverse reactions publicized

Nausea, weight change.

Caution against use:

During first trimester of pregnancy.

Adverse reactions publicized

Dry mouth, constipation, itching, sweating.

Tetracycline Ovulen Imipramine
CENTRAL AMERICA Caution against use:

None.

Adverse reactions publicized

None

Caution against use:

If patient has tendency to blood clot, liver dysfunction.

Adverse reactions publicized

Nausea, weight change.

Caution against use:

If patient has heart disease.

Adverse reactions publicized

None

Tetracycline Ovulen Imipramine
BRAZIL Caution against use:

By infants, children; during pregnancy.

Adverse reactions publicized

Vomiting, nausea, upset stomach, rashes.

Caution against use:

If patient has tendency to blood clot.

Adverse reactions publicized

None

Caution against use:

If patient has heart disease. Not recommended for children or during pregnancy.

Adverse reactions publicized

None

Tetracycline Ovulen Imipramine
ARGENTINA Caution against use:

None

Adverse reactions publicized

None

Caution against use:

If patient has tendency to blood clot.

Adverse reactions publicized

None

Caution against use:

May exaggerate response to alcohol.

Adverse reactions publicized

None

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate